Alberto Zacarias is Site Head of AbbVie Redwood City (ABR), a state-of-the-art AbbVie R&D center focused on discovery and early development of novel oncology therapies. Key responsibilities include defining and advancing the mission, vision, goals, and culture of ABR. As site lead for all business functions based at ABR (i.e., Finance, Human Resources, Site Services, IT, Legal, Global Commercial Development, Search and Evaluation, Business Development, Ventures, etc.), Alberto is also responsible for resolving any operational issues related to the site. Prior to joining AbbVie in 2013, Alberto was the founder and president of the Zantos Group, LLC, a consulting firm that provided new product planning and portfolio-management advice to biotechnology and pharmaceutical companies in the Bay Area, including Anacor Pharmaceuticals (now Pfizer) and AcelRx Pharmaceuticals. Before founding the Zantos Group, Alberto was in charge of the New Product Planning and Portfolio Management Group at Nektar Therapeutics. He has also worked in New Product Planning/Global Strategic Marketing at Johnson & Johnson, ALZA Pharmaceuticals, and Searle Pharmaceuticals (now Pfizer).
Alberto holds an MBA from the University of Chicago, and an MS and BS in Engineering from Boston University.